The proposed 1-for-1 bonus issue of shares will enlarge the existing 1.88bn share base to 3.76bn, or 3.84bn assuming all ESOS are exercised and treasury shares resold. The aim is to further enhance the trading liquidity of VSI’s shares. Both corporate exercises are expected to be completed by 2Q21.
VSI also proposed free warrants on the basis of 1 warrant for every 5 shares, up to 768.2m warrants. The warrant will have an expiry tenure of 3 years. The exercise price has not been determined, but based on an illustrative warrant price of RM1.50 (representing the theoretical ex-bonus price), VSI is expected to raise up to RM1.15bn, assuming the rights are fully exercised. Out of the total proceeds, 50% (RM576.2m) has been earmarked for future expansion of facilities, 30% (RM345.8m) for working capital and the remaining 20% (RM230.5m) to repay bank borrowing.
Similar to our recent upgrade on ATAIMS, we also raise our target price for VSI to RM3.78 (from RM3.20) after pegging it to a higher PE multiple of 26x (from 22x) on the CY21 EPS. We believe the rerating is justified given the scarcity premium for growth sectors locally and the EMS sector is expected to broadly benefit from more MNCs diverting more of their manufacturing operations to Malaysia. On that positive note, we expect VSI to be a prime beneficiary given its diversified customer mix. VSI remains our preferred sector pick and we reiterate our BUY rating.
Downside risks include: 1) lower customer orders; 2) potential foreign labor issue, 3) prolonged US-China trade stand-off, and 4) worsening global economic environment.
Source: Affin Hwang Research - 26 Feb 2021
Chart | Stock Name | Last | Change | Volume |
---|
Created by kltrader | Jan 03, 2023
Created by kltrader | Sep 30, 2022